Immucell Corp
ICCC- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000811641
No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Immucell Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q2 2023
- Shares held
- 1.03M
- −23.6K (−2.2%) vs. Q2 2023
- Total value
- $5.47M
- +$151.2K (+2.8%) vs. Q2 2023
- New holders
- 3
- 6 more added
- Sold out
- 4
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ICCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.4M |
| Q1 2026 | 27 | $8.67M |
| Q4 2025 | 26 | $7.87M |
| Q3 2025 | 27 | $8.08M |
| Q2 2025 | 25 | $9.00M |
| Q1 2025 | 27 | $5.79M |
| Q4 2024 | 27 | $6.21M |
| Q3 2024 | 22 | $4.27M |
| Q2 2024 | 28 | $5.56M |
| Q1 2024 | 25 | $5.39M |
| Q4 2023 | 28 | $5.31M |
| Q3 2023 | 30 | $5.47M |
| Q2 2023 | 31 | $5.32M |
| Q1 2023 | 30 | $5.42M |
| Q4 2022 | 26 | $5.41M |
| Q3 2022 | 26 | $7.26M |
| Q2 2022 | 29 | $8.53M |
| Q1 2022 | 27 | $9.18M |
| Q4 2021 | 29 | $7.04M |
| Q3 2021 | 28 | $8.05M |
| Q2 2021 | 28 | $7.45M |
| Q1 2021 | 28 | $7.20M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Immucell Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 205,097 | $1.10M | 0.00% | −1,228−0.6% | Reduced |
| Renaissance Technologies LLC | 121,380 | $648.0K | 0.00% | −1,009−0.8% | Reduced |
| Bleichroeder LP | 101,594 | $542.5K | 0.13% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 103,606 | $534.6K | 0.00% | +3,100+3.1% | Added |
| Morgan Stanley | 87,874 | $469.2K | 0.00% | +12,900+17.2% | Added |
| Shufro Rose & Co LLC | 62,408 | $333.3K | 0.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 57,594 | $297.2K | 0.00% | −6,670−10.4% | Reduced |
| Geode Capital Management, LLC | 53,213 | $274.7K | 0.00% | +7,486+16.4% | Added |
| Overbrook Management Corp | 32,857 | $175.5K | 0.04% | 00.0% | Unchanged |
| Strategic Financial Services, Inc, | 31,000 | $160.0K | 0.01% | 00.0% | Unchanged |
| Perritt Capital Management Inc | 27,026 | $144.3K | 0.08% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 21,354 | $111.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,556 | $90.6K | 0.00% | +434+2.5% | Added |
| BlackRock Inc. | 16,430 | $87.7K | 0.00% | −637−3.7% | Reduced |
| Prosperity Planning, Inc. | 16,000 | $85.4K | 0.04% | 00.0% | Unchanged |
| Wealth Effects LLC | 15,617 | $83.4K | 0.04% | −500−3.1% | Reduced |
| Citadel Advisors LLC | 15,019 | $77.5K | 0.00% | +3,806+33.9% | Added |
| Northern Trust Corp | 12,865 | $68.7K | 0.00% | +788+6.5% | Added |
| Essex Financial Services, Inc. | 11,000 | $58.7K | 0.01% | −3,000−21.4% | Reduced |
| Mission Wealth Management, LP | 10,000 | $53.4K | 0.00% | +10,000 | New |
| HM Payson & Co | 6,000 | $31.0K | 0.00% | −6,130−50.5% | Reduced |
| Headinvest, LLC | 3,118 | $16.3K | 0.00% | +3,118 | New |
| Bank of America Corp | 2,032 | $10.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,635 | $8.73K | 0.00% | −2,767−62.9% | Reduced |
| UBS Group AG | 1,596 | $8.52K | 0.00% | −104−6.1% | Reduced |
| US Bancorp | 600 | $3.20K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 152 | $812 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 40 | $214 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 7 | $36 | 0.00% | +7 | New |
| Royal Bank of Canada | 27 | $0 | 0.00% | −214−88.8% | Reduced |
| Empire Financial Management Company, LLC | 0 | $0 | 0.00% | −42,000−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −141−100.0% | Sold out |